共 116 条
[1]
Peyrin-Biroulet L(2008)Efficacy and safety of tumor necrosis factor antagonists in Crohn’s disease: meta-analysis of placebo-controlled trials Clin Gastroenterol Hepatol 6 644-653
[2]
Deltenre P(2005)Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2462-2476
[3]
de Suray N(2004)Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn’s disease Inflamm Bowel Dis 10 657-660
[4]
Rutgeerts P(2008)Risk factors for opportunistic infections in patients with inflammatory bowel disease Gastroenterology 134 929-936
[5]
Sandborn WJ(2004)Diagnosis, management, and treatment of hepatitis C Hepatology 39 1147-1171
[6]
Feagan BG(1998)Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection Clin Exp Immunol 111 269-277
[7]
Velayos FS(1996)IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C Dig Dis Sci 41 315-321
[8]
Sandborn WJ(1997)Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection Dig Dis Sci 42 2487-2494
[9]
Toruner M(1996)Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C Liver 16 390-399
[10]
Loftus EV(1996)Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C Hepatology 23 210-217